Early Postoperative Triple Targeted Therapy in Patients With CHD-PAH in the "Grey Zone"

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to observe the efficacy of early application of triple targeted drug therapy, including trilostane, in patients with congenital heart disease who are in the \"gray zone\" of preoperative evaluation, have surgical repair indications after evaluation, and have undergone defect repair.
Epistemonikos ID: 89d23e647a834d965232e8912a97e00ef33de56f
First added on: Sep 29, 2026